⌘K

Login Start Free

Home/Filings/4/0001209191-22-005557

4//SEC Filing

Yazji Salim 4

Accession 0001209191-22-005557

CIK 0001260990other

View on SEC.gov Company Profile

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 4:00 PM ET

Size

4.6 KB

Accession

0001209191-22-005557

Insider Transaction Report

Form 4

Period: 2022-01-27

Oncternal Therapeutics, Inc.ONCT

Chief Medical Officer

Transactions

Purchase
Common Stock
2022-01-27$1.69/sh+10,000$16,900→ 67,137 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Oncternal Therapeutics, Inc.

CIK 0001260990

Entity typeother

Related Parties

1

filerCIK 0001864486

Filing Metadata

Form type: 4
Filed: Jan 30, 7:00 PM ET
Accepted: Jan 31, 4:00 PM ET
Size: 4.6 KB

View on SEC.gov